Thomas J. Shaw Purchases 33,524 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 33,524 shares of the firm’s stock in a transaction that occurred on Friday, April 11th. The shares were bought at an average cost of $0.69 per share, with a total value of $23,131.56. Following the completion of the purchase, the chief executive officer now owns 15,201,112 shares of the company’s stock, valued at $10,488,767.28. This trade represents a 0.22 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.

Retractable Technologies Stock Up 0.9 %

Shares of NYSE:RVP opened at $0.71 on Wednesday. The company has a 50 day moving average price of $0.75 and a two-hundred day moving average price of $0.73. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The company has a market capitalization of $21.19 million, a PE ratio of -1.31 and a beta of 2.28. Retractable Technologies, Inc. has a 52 week low of $0.56 and a 52 week high of $1.22.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. Wealthfront Advisers LLC purchased a new position in Retractable Technologies, Inc. (NYSE:RVP) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned approximately 8.46% of Retractable Technologies at the end of the most recent reporting period. Institutional investors own 7.58% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Retractable Technologies in a research report on Saturday. They set a “hold” rating for the company.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.